Authors
Latest:
Study Finds Cancer Risk Increases as Physical Activity DecreasesSpending all day sitting on the couch to binge watch your favorite television show not only isn't great for your waistline, recent research suggests it could increase your risk for cancer.
Latest:
Michelle Farnan Discusses the Challenges of Integrating Palliative CareMichelle Farnan, RN, MSN, OCN, palliative care nurse coordinator, Penn State Hershey Medical Center, discusses the challenges of integrating palliative care into practice.
Latest:
Anita Mahajan on Patient Education for Patients with Brain CancerAnita Mahajan discusses the important points that nurses should include in their patient education for patients with brain cancer.
Latest:
Long-Term Cancer Treatment-A Patient's PerspectiveHaving been in palliative care since 2006, my face is a familiar one at the cancer center. While it has bought me 12 years so far, and hopefully many more, I'm still trying to navigate a "new normal."
Latest:
Caregivers, Healthcare Workers, and Patients Up in Arms Against the FluCaregivers of people with cancer should get flu shots.
Latest:
Connecting All the Pieces: Helping Patients Make Sense of Their ChemotherapyChemotherapy education is a puzzle personalized for each patient. Each piece of the puzzle represents a different method of instruction to supplement nurses’ interpersonal teaching.
Latest:
Firstline Olaparib-Based Treatment Improves PFS, Responses in mCRPCFrontline olaparib plus abiraterone/prednisone improved progression-free survival and responses in patients with metastatic castration-resistant prostate cancer compared with each of the components of the therapy alone.
Latest:
Stress Management for NursesStress management is vital for any profession, but for oncology nurses, stress management is crucial to not only helping themselves but also helping their patients.
Latest:
Talking About the Cost of Cancer Care With PatientsDuring a session at the 2018 ASCO Annual Meeting, June 1-5, in Chicago, Illinois, Nipp and fellow panelists Ellen Miller Sonet, MBA, JD, chief strategy and policy officer, CancerCare, and Gery P. Guy Jr, PhD, MPH, of the Centers for Disease Control and Prevention, discussed the financial burdens of cancer diagnosis and treatment, the barriers facing clinicians and patients in discussing these financial burdens, and solutions that can be implemented to alleviate the burden.
Latest:
Dr. Vahdat Discusses the Side Effects of HalavenDr. Linda Vahdat, from New York-Presbyterian Hospital, Discusses the Side Effects of Halaven
Latest:
Joan Lockhart on Follow-Up Care for Patients With Head and Neck CancerJoan Lockhart, PhD, RN, CORLN, AOCN, CNE, ANEF, FAAN, clinical professor at Duquesne University School of Nursing, discusses issues oncology nurses should monitor for when treating patients with head and neck cancer.
Latest:
Building Trust and Giving Voice to the Patient's WishesLinda told me the too often heard story of a routine chest x-ray before surgery, and suddenly, the anxiety over having a gallbladder removed was overshadowed by the news that the x-ray revealed a large lung mass.
Latest:
Revisiting My Interview With Suzanne SomersSuzanne Somers had her critics, but many applauded her approach to health care and cancer.
Latest:
Predicting Immunotherapy Response in Bladder CancerPD-L1 status may not be the best predictor when it comes to determining who will respond to checkpoint blockade.
Latest:
Mirvetuximab Soravtansine Bests Chemo in HRQOL for FRα+ Ovarian CancerFurther evidence strengthens the support of mirvetuximab soravtansine as a new standard of care for folate receptor-alpha—positive ovarian cancer resistant to platinum chemotherapy.
Latest:
Elena Ratner on Menopause and Breast Cancer TreatmentsDr. Elena Ratner discusses the interaction between menopause and certain treatments for breast cancer.
Latest:
Adding Nivolumab to Chemotherapy Improves Survival Rates in Metastatic Urothelial CarcinomaNivolumab plus gemcitabine-cisplatin improved overall and progression-free survival in unresectable or metastatic urothelial carcinoma.
Latest:
Pamela Devine Discusses Psychosocial Issues Concerning Men with Prostate CancerPamela Devine, RN, clinical nurse specialist, Philadelphia Veterans Administration Medical Center, discusses some of the psychosocial issues that men face when they are receiving treatment for their prostate cancer.
Latest:
What to Do When a Patient Brings in Direct-to-Consumer Genetic Test Results for Your ReviewA guide for oncology nurses on navigating the ever-growing field of direct-to-consumer genetic testing.
Latest:
Helping Caregivers and Families Feel More Able to ManageCaregivers of young adult survivors (YAS) of childhood brain tumors, usually their mothers, live dramatically altered lives as they incorporate illness management into family life and function in caregiving roles well into the survivors’ adulthood.
Latest:
Frontline Treatment of Metastatic NSCLC Depends on Biomarkers and HistologyChoosing frontline therapy for patients with metastatic non–small cell lung cancer (NSCLC) who do not harbor an actionable driver oncogene depends upon PD-L1 expression level and histology, according to Gregory J. Riely, MD, PhD.
Latest:
Jae Park on Clinical Trials for CAR T-Cell Activation TherapyJae Park, MD, hematologist-oncologist, Memorial Sloan Kettering Cancer Center, talks about CAR T-cell activation therapy, which is currently in clinical trials for patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma.
Latest:
Olga Ivanov Discusses Sexual Health After Risk-Reducing Cancer SurgeryOlga Ivanov, MD, breast cancer surgeon at the Florida Hospital Cancer Institute, discusses sexual difficulties women who have had risk-reducing cancer surgery face.
Latest:
Kim Christen on Creating a Patient-Driven Protocol for the Specialty PharmacyKim Christen, RN, BSN, OCN, of Kootenai Clinic Cancer Services discusses the process of creating a protocol for the onsite pharmacy at Kootenai that keeps patients at the center.
Latest:
Using Antibiotics Could Affect Checkpoint InhibitorsA recent study presented at the 2017 Genitourinary Cancers Symposium found that use of antibiotics could damper the efficacy of checkpoint inhibitors, potentially due to the relationship between gut microbiota and antibiotics.
Latest:
Do Targeted Therapies Drive Disparities?After the widespread use of targeted therapies for breast cancer treatment, there was a wider gap in mortality rates between black and white women with the disease.
